Rail technology firm ZTR and communications and security software provider BlackBerry, Limited (NYSE: BB) are partnering to devise a system to help railcar owners, operators and suppliers monitor their railcars remotely, both companies said today.The new offering would enable owners, operators and suppliers to gain more insight in managing their fleets, while extending the battery life of their monitoring devices, according to both. "Like many industries, freight rail customers are interested in a higher level of service relating to their deliveries. This higher expectation is driven by consumer experiences in industries that allow them to know where a taxi pick up, or pizza delivery is at any given moment," ZTR Director of Sales Brian Nelson told FreightWaves. Minneapolis-based ZTR's offerings include an Internet of Things (IoT) division that provides remote equipment monitoring as well as a technology division to modernize locomotives. ZTR's IoT division would be involved in this partnership. Meanwhile, Waterloo, Ontario-based...
With many programs unable to complete their renewal applications and compliance reviews due to the difficult times we are facing, the National Institute for Automotive Service Excellence (ASE) has extended its deadlines for accredited programs. ...
If Walt Disney Co (NYSE: DIS) was a pure theme park company, there would be a reason for "massive concerns." But this isn't the case, Michael Bapis, managing director at Vios Advisors at Rockefeller Capital Management said last Friday on a CNBC "Trading Nation" segment.Disney's Diversified Business Disney's business has evolved over the past five to seven years to the point where it's now heavily diversified, Bapis said. Most recently, the launch of the Disney+ streaming platform gives the company a new direct to consumer business and media distribution strategy.The company's theme parks unit "will hurt" in the near-term due to the coronavirus (COVID-19) pandemic and some level for pain could linger on for up to two years, he said. But in the interim, the streaming business offers a form of offset to lost revenue."It's just a product of the environment, it's a product of the markets that are just a...
Dr. Ezekiel Emanuel, Former White House Health Policy Advisor for the Obama Administration and Vice Provost of Global Initiatives at the University of Pennsylvania, joins Yahoo Finance’s Seana Smith to discuss the coronavirus outbreak, as the U.S. death toll surpasses 10,000....
Gilead Sciences (GILD) has positioned itself at the front line in the global war against COVID-19. The biotech’s experimental drug remdesivir is currently in two Gilead sponsored Phase 3 trials in over 90 locations, and two further investigator sponsored Phase 3 trials in China. The drug is currently registered in 11 ongoing trials, from which a handful of data readouts are expected in the next 2 to 6 weeks.So far, remdesivir has shown powerful in vitro efficacy against RNA viruses in cell-based assays and evidence of efficacy in both in California and Washington states; Additionally, there has also been some anecdotal evidence from American cruise passengers, as well as locals, treated in Japan.Oppenheimer’s Hartaj Singh noted, “We believe GILD likely has further positive in-vitro data from Chinese CDC in nonhuman primate (NHP) cells and potentially also from US CDC in human cells.” Yet, Singh remains “cautious going into the impending data...
